New therapy (I hope I am not repeating myself)

[Maxone73]

urologytimes.com/view/antib...

The novel antibody-drug conjugate PDS0301 (M9241) in combination with docetaxel demonstrated promising safety and immune response signals in patients with metastatic castration-sensitive prostate cancer (mCSPC) and metastatic castration-resistant prostate cancer (mCRPC), according to interim results from a phase 1/2 clinical trial (NCT04633252) announced by PDS Biotech, the developer of the therapy, in a news release.

[Soumen79]

No you are not repeating yourself, you are some forward looking person and in this ugly combat more people like you are needed.

Please keep on your great work.

[Maxone73 in reply to Soumen79]

Just scared like hell...and trying to use what was part of my job as researcher to help myself and others to face this thing, I just don't want to post the same research twice (unless there are developments of course, and I am strongly hoping that arx517 will bring great news in a couple of weeks)

[j-o-h-n in reply to Maxone73]

The key to not repeating myself is.............. I mumble all the time, so no one understands me anyway....

Good Luck, Good Health and Good Humor.

j-o-h-n Saturday 10/14/2023 2:59 PM DST

[Maxone73 in reply to j-o-h-n]

I mumble as well...problem is I do it while talking to myself, then I complain because I don't understand myself!

[reb77 in reply to Maxone73]

Right. I am following Ambrx (AMAM) very closely and with some hope.

[Maxone73 in reply to reb77]

to be honest I was hoping to buy some shares in the company as well, but it looks like they are on nasdaq but not trading at the moment...

[Maxone73 in reply to reb77]

I don’t know if you missed this but check the comments in the post linked within this:

healthunlocked.com/advanced...

I have a feeling that you will like it!